DDR1
Basic information
Region (hg38): 6:30876421-30900156
Previous symbols: [ "NTRK4", "PTK3A", "NEP", "CAK", "EDDR1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DDR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 36 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 5 | 0 |
Variants in DDR1
This is a list of pathogenic ClinVar variants found in the DDR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-30888778-A-G | Likely benign (Jun 05, 2018) | |||
6-30888935-A-G | not specified | Uncertain significance (Oct 01, 2024) | ||
6-30889004-A-G | not specified | Uncertain significance (Feb 21, 2024) | ||
6-30889209-A-G | not specified | Uncertain significance (Jul 26, 2021) | ||
6-30889296-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
6-30889416-C-T | not specified | Uncertain significance (Nov 15, 2024) | ||
6-30889417-G-A | not specified | Uncertain significance (Nov 04, 2023) | ||
6-30891025-C-T | not specified | Uncertain significance (Sep 25, 2024) | ||
6-30891069-C-T | not specified | Uncertain significance (Jun 25, 2024) | ||
6-30891111-C-T | not specified | Uncertain significance (Oct 17, 2024) | ||
6-30891383-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
6-30891400-G-T | not specified | Uncertain significance (Sep 02, 2024) | ||
6-30891406-G-C | not specified | Uncertain significance (Mar 04, 2024) | ||
6-30891422-A-G | not specified | Uncertain significance (Jan 30, 2024) | ||
6-30892127-C-T | not specified | Uncertain significance (Feb 12, 2024) | ||
6-30892329-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
6-30892360-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
6-30892488-C-T | not specified | Uncertain significance (Jan 13, 2023) | ||
6-30892489-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
6-30892501-C-T | not specified | Uncertain significance (May 24, 2023) | ||
6-30892530-T-C | not specified | Uncertain significance (Dec 21, 2022) | ||
6-30893073-G-A | not specified | Likely benign (Oct 19, 2024) | ||
6-30893089-C-T | not specified | Likely benign (May 02, 2024) | ||
6-30893110-C-T | not specified | Uncertain significance (Dec 07, 2024) | ||
6-30893115-G-C | not specified | Uncertain significance (Oct 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DDR1 | protein_coding | protein_coding | ENST00000376575 | 17 | 23736 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000463 | 1.00 | 125695 | 0 | 53 | 125748 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.22 | 454 | 608 | 0.746 | 0.0000403 | 5910 |
Missense in Polyphen | 109 | 163.49 | 0.66672 | 1586 | ||
Synonymous | 1.85 | 208 | 245 | 0.850 | 0.0000157 | 1939 |
Loss of Function | 3.74 | 17 | 43.7 | 0.389 | 0.00000225 | 451 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000180 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000356 | 0.000343 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000165 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Tyrosine kinase that functions as cell surface receptor for fibrillar collagen and regulates cell attachment to the extracellular matrix, remodeling of the extracellular matrix, cell migration, differentiation, survival and cell proliferation. Collagen binding triggers a signaling pathway that involves SRC and leads to the activation of MAP kinases. Regulates remodeling of the extracellular matrix by up-regulation of the matrix metalloproteinases MMP2, MMP7 and MMP9, and thereby facilitates cell migration and wound healing. Required for normal blastocyst implantation during pregnancy, for normal mammary gland differentiation and normal lactation. Required for normal ear morphology and normal hearing (By similarity). Promotes smooth muscle cell migration, and thereby contributes to arterial wound healing. Also plays a role in tumor cell invasion. Phosphorylates PTPN11. {ECO:0000250, ECO:0000269|PubMed:12065315, ECO:0000269|PubMed:16234985, ECO:0000269|PubMed:16337946, ECO:0000269|PubMed:19401332, ECO:0000269|PubMed:20093046, ECO:0000269|PubMed:20432435, ECO:0000269|PubMed:20884741, ECO:0000269|PubMed:21044884, ECO:0000269|PubMed:9659899}.;
- Pathway
- Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway;Extracellular matrix organization;Non-integrin membrane-ECM interactions
(Consensus)
Recessive Scores
- pRec
- 0.343
Intolerance Scores
- loftool
- 0.0429
- rvis_EVS
- -1.26
- rvis_percentile_EVS
- 5.31
Haploinsufficiency Scores
- pHI
- 0.615
- hipred
- Y
- hipred_score
- 0.627
- ghis
- 0.525
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.988
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ddr1
- Phenotype
- growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; hearing/vestibular/ear phenotype; craniofacial phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; skeleton phenotype;
Gene ontology
- Biological process
- regulation of cell growth;regulation of cell-matrix adhesion;cell adhesion;cell-matrix adhesion;transmembrane receptor protein tyrosine kinase signaling pathway;embryo implantation;lactation;positive regulation of cell population proliferation;negative regulation of cell population proliferation;regulation of extracellular matrix disassembly;smooth muscle cell migration;cell differentiation;extracellular matrix organization;collagen-activated tyrosine kinase receptor signaling pathway;peptidyl-tyrosine autophosphorylation;ear development;wound healing, spreading of cells;protein autophosphorylation;branching involved in mammary gland duct morphogenesis;mammary gland alveolus development;smooth muscle cell-matrix adhesion;axon development;regulation of extracellular matrix organization;neuron projection extension
- Cellular component
- extracellular space;plasma membrane;integral component of plasma membrane;receptor complex;extracellular exosome
- Molecular function
- transmembrane receptor protein tyrosine kinase activity;protein binding;collagen binding;ATP binding;protein tyrosine kinase collagen receptor activity;metal ion binding